why choose us

First received: July 11, 2024

Clinical Trial: A Study of TAK-861 in People With Narcolepsy Type 1

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Narcolepsy Type 1

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)

Brief Summary: The main aim of this study is to learn how effective TAK-861 is in improving excessive sleepiness during the day (called excessive daytime sleepiness or EDS) after 3 months of treatment.Other aims are to learn how effective TAK-861 is in lowering the number of sudden, unexpected attacks of muscle weakness while staying conscious (cataplexy) in a week; to learn the effect TAK-861 has on participants' ability to maintain attention, participant's overall quality of life, the spectrum of narcolepsy symptoms…

Read more